Katja Wosikowski

Identification of Epidermal Growth Factor Receptor and c-erbB2 Pathway Inhibitors by Correlation With Gene Expression Patterns

Katja Wosikowski, Danita H. Schuurhuis, K. Johnson et al. · JNCI Journal of the National Cancer Institute · 1997 · 118 citations · Full text

Medicine, Oncology, Pharmacology +9

In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.

Katja Wosikowski, Elfi Biedermann, Benno Rattel et al. · PubMed · 2003 · 115 citations

Medicine, Oncology, Pharmacology +14

Altered gene expression in drug-resistant human breast cancer cells.

Katja Wosikowski, Danita H. Schuurhuis, Geert J.P.L. Kops et al. · PubMed · 1997 · 91 citations

Medicine, Cancer Biology, Oncology +14

WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.

Katja Wosikowski, Karin Mattern, Isabel Schemainda et al. · PubMed · 2002 · 89 citations

Life Sciences, Oncology, Pharmacology +17

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Katja Wosikowski, Joanna Regis, Robert W. Robey et al. · PubMed · 1995 · 72 citations

Medicine, Oncology, Pharmacology +17